STEPHEN C KNIGHT, M.D.
Osteopathic Medicine in Cambridge, MA
License number
Massachusetts 152622
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
One Main St, Cambridge, MA 02142
Phone
(617) 231-2401
Organization information
See more information about STEPHEN C KNIGHT at bizstanding.comStephen C Knight MD
1 Main St, Cambridge, MA 02142
Categories:
Internal Medicine Physicians & Surgeons
Phone:
(617) 231-2420 (Phone)
Professional information
Managing Partner At Fidelity Biosciences
Position:
President & Managing Partner at Fidelity Biosciences
Location:
Greater Boston Area
Industry:
Venture Capital & Private Equity
Work:
Fidelity Biosciences
since Oct 2003
-
President & Managing Partner
Foldrx Pharmaceuticals
- Cambridge, MA Dec 2004 - Oct 2010
-
Director
Respivert
- London, UK Jan 2006 - Jun 2010
-
Board of Directors
Ironwood Pharmaceuticals
Jan 2004 - Feb 2010
-
Director
US Genomics
2003 - 2010
-
Board of Directors
Veritas Medicine
1999 - 2007
-
Chairman
Pharmos
- New Jersey Jun 1994 - Jun 1999
-
Director
Education:
Yale University - Yale School of Management 1988 - 1990
MBA Yale University School of Medicine 1985 - 1990
MD Columbia University in the City of New York 1981 - 1983
BS, Biology
MBA Yale University School of Medicine 1985 - 1990
MD Columbia University in the City of New York 1981 - 1983
BS, Biology
Dr. Stephen C Knight, Cambridge MA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
1 Main St STE 13TH, Cambridge 02142
(617) 231-2401 (Phone), (617) 231-2425 (Fax)
(617) 231-2401 (Phone), (617) 231-2425 (Fax)
Languages:
English
Education:
Medical School
Yale University
Graduated: 1990
Mt Auburn Hospital
Yale University
Graduated: 1990
Mt Auburn Hospital
Stephen Christian Knight, Cambridge MA
Specialties:
Internal Medicine
Work:
Fidelity Biosciences
1 Main St, Cambridge, MA 02142
1 Main St, Cambridge, MA 02142
Education:
Yale University (1990)
Imaging Sexual Response
US Patent:
2006001, Jan 26, 2006
Filed:
Jul 18, 2005
Appl. No.:
11/184271
Inventors:
Robert Weisskoff - Lexington MA, US
Stephen Knight - Cambridge MA, US
Wayne Carter - Branford CT, US
Stephen Knight - Cambridge MA, US
Wayne Carter - Branford CT, US
International Classification:
A61K 49/00
US Classification:
424009200
Abstract:
The present invention relates to methods for contrast-enhanced imaging of sexual response. In particular, the present invention relates to methods of magnetic resonance imaging (MRI), computerized X-ray tomography (CT), ultrasound, and optical imaging using contrast agents to measure blood flow during sexual response, especially female sexual response. The invention relates to methods of analyzing normal sexual function and sexual dysfunction and provides a means for evaluating and screening potential therapeutic compounds for enhancing sexual function or treating sexual dysfunction.
Recruiting A Patient Into A Clinical Trial
US Patent:
7904313, Mar 8, 2011
Filed:
Aug 23, 2001
Appl. No.:
09/938295
Inventors:
Stephen C. Knight - Cambridge MA, US
Assignee:
Quintiles, Inc. - Durham NC
International Classification:
G06F 19/00, G06F 15/16
US Classification:
705 3, 726 11, 705 2
Abstract:
Techniques are described for recruiting a patient into a clinical trial, including receiving patient-specific data from a remote network device at a server, accessing criteria of more than one clinical trial at the server, and determining one or more clinical trials having criteria satisfied by the patient-specific data.
Imaging Sexual Response
US Patent:
6969507, Nov 29, 2005
Filed:
Nov 8, 2002
Appl. No.:
10/291900
Inventors:
Robert M. Weisskoff - Lexington MA, US
Stephen C. Knight - Cambridge MA, US
Wayne Carter - Branford CT, US
Stephen C. Knight - Cambridge MA, US
Wayne Carter - Branford CT, US
Assignee:
Epix Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K049/00, A61B005/055
US Classification:
424 92, 424 91, 424 93
Abstract:
The present invention relates to methods for contrast-enhanced imaging of sexual response. In particular, the present invention relates to methods of magnetic resonance imaging (MRI), computerized X-ray tomography (CT), ultrasound, and optical imaging using contrast agents to measure blood flow during sexual response, especially female sexual response. The invention relates to methods of analyzing normal sexual function and sexual dysfunction and provides a means for evaluating and screening potential therapeutic compounds for enhancing sexual function or treating sexual dysfunction.